PEMFEXY Trademark

Trademark Overview

On Friday, July 12, 2019, a trademark application was filed for PEMFEXY with the United States Patent and Trademark Office. The USPTO has given the PEMFEXY trademark a serial number of 88512003. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by Eagle Pharmaceuticals Inc.. The PEMFEXY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of lung cancer
pemfexy

General Information

Serial Number88512003
Word MarkPEMFEXY
Filing DateFriday, July 12, 2019
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6754731
Registration DateTuesday, June 7, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Description of MarkThe mark consists of the term "PEMFEXY", with the letters "P" "E" "M" F" "E" and "Y" in the color dark blue, while the letter "X" and the tear drop that is centered over the "X" both appear in the color light blue.
Goods and ServicesPharmaceutical preparations for treatment of lung cancer
Indication of Colors claimedThe color(s) dark blue and light blue is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 18, 2019
Primary Code005
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

Trademark Owner History

Party NameEagle Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677
Party NameEagle Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677
Party NameEagle Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 07677

Trademark Events

Event DateEvent Description
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 19, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 6, 2022USE AMENDMENT FILED
Tuesday, April 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 6, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU EXTENSION 4 GRANTED
Monday, December 20, 2021SOU EXTENSION 4 FILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 3 GRANTED
Monday, June 14, 2021SOU EXTENSION 3 FILED
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Thursday, December 17, 2020SOU TEAS EXTENSION RECEIVED
Thursday, July 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 30, 2020SOU EXTENSION 1 GRANTED
Tuesday, June 30, 2020SOU EXTENSION 1 FILED
Tuesday, June 30, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 28, 2019ASSIGNED TO EXAMINER
Friday, July 19, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 16, 2019NEW APPLICATION ENTERED

Related Keywords

pemfexy cancer lung treatment preparations pharmaceutical